Gene: MYG1
Official Full Name: MYG1 exonucleaseprovided by HGNC
Gene Summary: Enables 3'-5'-RNA exonuclease activity. Involved in mRNA processing; mitochondrial RNA metabolic process; and rRNA processing. Located in mitochondrion and nucleus. Is active in mitochondrial matrix; nucleolus; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04572 | MYG1 Knockout cell line (HeLa) | Human | MYG1 | 1:3~1:6 | Negative | Online Inquiry |
KO04573 | MYG1 Knockout cell line (HCT 116) | Human | MYG1 | 1:2~1:4 | Negative | Online Inquiry |
KO04574 | MYG1 Knockout cell line (HEK293) | Human | MYG1 | 1:3~1:6 | Negative | Online Inquiry |
KO04575 | MYG1 Knockout cell line (A549) | Human | MYG1 | 1:3~1:4 | Negative | Online Inquiry |
MYG1 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of MYG1 gene function in various biological contexts. These cell lines have undergone precise genomic editing, resulting in a complete knockout of the MYG1 gene, which plays a crucial role in cell growth, differentiation, and metabolism. By employing advanced CRISPR-Cas9 gene-editing technology, these cell lines enable researchers to investigate the phenotypic consequences of MYG1 deletion in a regulated laboratory environment.
The primary function of MYG1 Gene Knockout Cell Lines lies in their ability to serve as powerful tools for elucidating the biological pathways influenced by the MYG1 gene. Researchers can assess how MYG1 disruption affects cellular processes such as apoptosis, proliferation, and response to stressors, thereby linking gene activity to physiological outcomes. This understanding is invaluable not only in basic biological research but also in the development of targeted therapies that may address MYG1-associated diseases.
In terms of scientific importance, these knockout cell lines are particularly relevant in oncology, regenerative medicine, and metabolic studies. By utilizing MYG1 Gene Knockout Cell Lines, scientists can explore potential tumorigenic effects, tissue regeneration mechanisms, and metabolic dysregulation—areas that are critical in developing innovative medical interventions.
What sets MYG1 Gene Knockout Cell Lines apart from similar biological products is their high specificity and validated background, which reduce the likelihood of off-target effects commonly observed with less advanced editing techniques. Additionally, each cell line is characterized thoroughly, providing researchers with a detailed functional profile that enhances experimental reliability and reproducibility.
For researchers and clinicians aiming to uncover the complexities of gene function and its implications in health and disease, MYG1 Gene Knockout Cell Lines offer a valuable resource. These cell lines not only improve experimental designs but also expedite the discovery of novel therapeutic targets.
With years of experience in genetic engineering and a commitment to advancing biomedical research, our company specializes in providing top-tier biological products tailored to meet the needs of the scientific community. We strive to support cutting-edge research initiatives through reliable and innovative solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.